CTOR 8-K 2026-10-23

CITIUS ONCOLOGY, INC. (CTOR) 8-K dated 2026-10-23 — accession 0001213900-26-112109. This URL is the filing, not the CTOR hub.

CITIUS ONCOLOGY, INC. (CTOR) is a drug manufacturers - specialty & generic company listed on US.

CITIUS ONCOLOGY, INC. filed a 8-K on 2026-10-23. Accession 0001213900-26-112109.

Cached items: 8.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported CTOR revenue for 2026-06-30 was $1.5M. Net income was -$8.9M. Revenue was down 10.4% from 2026-03-31 to 2026-06-30. CTOR currently screens at market cap $105.2M.

Not investment advice. The CTOR SEC hub lists recent forms. The stock page is the research view.